121 related articles for article (PubMed ID: 6108409)
21. Plasmodium falciparum in Haiti: susceptibility to pyrimethamine and sulfadoxine-pyrimethamine.
Nguyen-Dinh P; Zevallos-Ipenza A; Magloire R
Bull World Health Organ; 1984; 62(4):623-6. PubMed ID: 6386210
[TBL] [Abstract][Full Text] [Related]
22. Pyrimethamine/sulfadoxine resistant falciparum malaria acquired at Dar es Salaam, Tanzania.
Stahel E; Degrémont A; Lagler U
Lancet; 1982 May; 1(8281):1118-9. PubMed ID: 6122905
[No Abstract] [Full Text] [Related]
23. Report of a case of P. falciparum malaria resistant to chloroquine and combination of sulfalene and pyrimethamine in Delhi.
Choudhury DS; Sinha S; Ghosh SK; Devi CU; Sharma VP
Indian J Malariol; 1987 Jun; 24(1):95-6. PubMed ID: 3326756
[No Abstract] [Full Text] [Related]
24. In vitro susceptibility of Plasmodium falciparum collected from pyrimethamine-sulfadoxine sensitive and resistant areas in Thailand.
Sabchareon A; Chongsuphajaisiddhi T; Attanath P; Kanjanapipatkul K; Doberstyn EB; Suebsaeng L
Bull World Health Organ; 1985; 63(3):597-602. PubMed ID: 3899396
[TBL] [Abstract][Full Text] [Related]
25. The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results.
Schapira A; Bygbjerg IC; Jepsen S; Flachs H; Bentzon MW
Am J Trop Med Hyg; 1986 Mar; 35(2):239-45. PubMed ID: 3513641
[TBL] [Abstract][Full Text] [Related]
26. Sulfadoxine-pyrimethamine for the treatment of acute malaria in children in Papua New Guinea. I. Plasmodium falciparum.
Darlow B; Vrbova H; Gibney S; Jolley D; Stace J; Alpers M
Am J Trop Med Hyg; 1982 Jan; 31(1):1-9. PubMed ID: 7036764
[TBL] [Abstract][Full Text] [Related]
27. RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia.
Hoffman SL; Rustama D; Dimpudus AJ; Punjabi NH; Campbell JR; Oetomo HS; Marwoto HA; Harun S; Sukri N; Heizmann P
Lancet; 1985 Nov; 2(8463):1039-40. PubMed ID: 2865518
[TBL] [Abstract][Full Text] [Related]
28. Comparison of in vitro pyrimethamine assays and in vivo response to sulphadoxine-pyrimethamine in Plasmodium falciparum from Papua New Guinea.
Lamont G; Darlow B
Trans R Soc Trop Med Hyg; 1982; 76(6):797-9. PubMed ID: 6761908
[TBL] [Abstract][Full Text] [Related]
29. Malaria in the province of Takeo, Cambodia.
Giboda M
Folia Parasitol (Praha); 1985; 32(3):205-10. PubMed ID: 3899874
[TBL] [Abstract][Full Text] [Related]
30. Plasmodium falciparum RI resistance to quinine and sulphadoxine-pyrimethamine in the Solomon Islands.
Isaacs RD; Ellis-Pegler RB
Med J Aust; 1987 Apr; 146(8):449-50. PubMed ID: 3302637
[No Abstract] [Full Text] [Related]
31. Susceptibility of Plasmodium falciparum to pyrimethamine and sulfadoxine/pyrimethamine in Kisumu, Kenya.
Nguyen-Dinh P; Spencer HC; Chemangey-Masaba S; Churchill FC
Lancet; 1982 Apr; 1(8276):823-5. PubMed ID: 6122056
[TBL] [Abstract][Full Text] [Related]
32. A case of fansidar-resistant Plasmodium falciparum from Tanzania.
De Geus A; Meuwissen JH; van Rijn A
Trop Geogr Med; 1982; 34(3):261-3. PubMed ID: 6758245
[No Abstract] [Full Text] [Related]
33. Multi-drug resistant malaria in Sri Lanka.
Gunasekera DP; Perera DP
Ceylon Med J; 1996 Dec; 41(4):170-1. PubMed ID: 9141768
[No Abstract] [Full Text] [Related]
34. Mefloquine-pyrimethamine-sulfadoxine combination delays emergence of mefloquine resistant Plasmodium falciparum in continuous culture.
Tan-Ariya P; Brockelman CR; Menabandhu C
Southeast Asian J Trop Med Public Health; 1984 Dec; 15(4):531-5. PubMed ID: 6398918
[TBL] [Abstract][Full Text] [Related]
35. The activity of pyrimethamine and sulphadoxine against Plasmodium falciparum determined by the in vitro microtechnique.
Eastham GM; Rieckmann KH
Trans R Soc Trop Med Hyg; 1983; 77(1):91-3. PubMed ID: 6344364
[TBL] [Abstract][Full Text] [Related]
36. Cross resistance of pyrimethamine and sulfadoxine to their related compounds in Plasmodium falciparum.
Tan-ariya P; Brockelman C
Southeast Asian J Trop Med Public Health; 1984 Mar; 15(1):7-11. PubMed ID: 6377515
[TBL] [Abstract][Full Text] [Related]
37. Pyrimethamine-sulfadoxine (Fansidar) resistance in a non-immune Kenyan--a case report.
Nevill CG; Gardner A
East Afr Med J; 1991 Feb; 68(2):149-51. PubMed ID: 2040235
[TBL] [Abstract][Full Text] [Related]
38. Resistance of Plasmodium falciparum in vivo to 3 days' treatment with quinine and single-dose Fansidar.
Al-Yaman F; Genton B; Mokela D; Alpers MP
P N G Med J; 1994 Mar; 37(1):54-6. PubMed ID: 7863730
[No Abstract] [Full Text] [Related]
39. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
[TBL] [Abstract][Full Text] [Related]
40. A 5-year surveillance of sensitivity in vivo of Plasmodium falciparum to pyronaridine/sulfadoxine/pyrimethamine in Diaoluo area, Hainan Province.
Shao BR; Huang ZS; Shi XH; Meng F
Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):65-7. PubMed ID: 1948261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
